Skip to main content

Mitosol FDA Approval History

FDA Approved: Yes (First approved February 7, 2012)
Brand name: Mitosol
Generic name: mitomycin
Dosage form: Ophthalmic Solution
Company: Mobius Therapeutics, LLC
Treatment for: Glaucoma Surgery

Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.

Development timeline for Mitosol

Feb  9, 2012Approval Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.